RELMADA THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense
RELMADA THERAPEUTICS, INC. (RLMD) reported Increase (Decrease) in Prepaid Expense of $402.43 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-05-12
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $402.43K.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2025-03-31 was -$290.05K.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2024-03-31 was -$432.72K.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2023-09-30 was -$627.38K.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expense for fiscal 2022 was -$7.26M, a 169.79% decline from fiscal 2021.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expense for fiscal 2021 was $10.40M, a 2070.05% increase from fiscal 2020.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expense for fiscal 2020 was $479.33K.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expense for fiscal 2019 was -$471.91K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $402.43K 10-Q · filed 2026-05-12 | |||
| 2025-03-31 | -$290.05K 10-Q · filed 2026-05-12 | |||
| 2024-03-31 | -$432.72K 10-Q · filed 2024-05-08 | |||
| 2023-09-30 | -$627.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$242.70K derived: sum of 2 quarters · filed 2023-11-08 | -$1.19M 10-Q · filed 2023-11-08 | -$88.08K derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-06-30 | $384.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$560.93K 10-Q · filed 2023-08-08 | $539.30K derived: sum of 3 quarters · filed 2024-05-08 | -$9.85K derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-03-31 | -$945.61K 10-Q · filed 2024-05-08 | $154.62K derived: sum of 2 quarters · filed 2024-05-08 | -$394.53K derived: sum of 3 quarters · filed 2024-05-08 | -$1.97M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $551.08K derived: sum of 2 quarters · filed 2023-11-08 | -$1.02M derived: sum of 3 quarters · filed 2023-11-08 | -$7.26M 10-K · filed 2023-03-23 |
| 2022-09-30 | -$549.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$2.12M derived: sum of 2 quarters · filed 2023-11-08 | -$8.36M 10-Q · filed 2023-11-08 | $229.36K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$7.81M 10-Q · filed 2023-08-08 | $778.50K derived: sum of 3 quarters · filed 2023-08-08 | $1.95M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$6.24M 10-Q · filed 2023-05-11 | $2.35M derived: sum of 2 quarters · filed 2023-05-11 | $3.52M derived: sum of 3 quarters · filed 2023-05-11 | $4.08M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $8.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $9.76M derived: sum of 2 quarters · filed 2023-03-23 | $10.31M derived: sum of 3 quarters · filed 2023-03-23 | $10.40M 10-K · filed 2023-03-23 |
| 2021-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.72M derived: sum of 2 quarters · filed 2022-11-10 | $1.81M 10-Q · filed 2022-11-10 | $466.28K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $558.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $645.69K 10-Q · filed 2022-08-11 | -$700.32K derived: sum of 3 quarters · filed 2022-08-11 | $1.31M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $87.50K 10-Q · filed 2022-05-05 | -$1.26M derived: sum of 2 quarters · filed 2022-05-05 | $750.16K derived: sum of 3 quarters · filed 2022-05-05 | $744.69K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $662.66K derived: sum of 2 quarters · filed 2022-03-25 | $657.18K derived: sum of 3 quarters · filed 2022-03-25 | $479.33K 10-K · filed 2022-03-25 |
| 2020-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.00M derived: sum of 2 quarters · filed 2021-11-12 | $1.83M 10-Q · filed 2021-11-12 | $1.87M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$5.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$183.33K 10-Q · filed 2021-08-10 | -$136.37K derived: sum of 3 quarters · filed 2021-08-10 | -$280.21K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$177.85K 10-Q · filed 2021-05-12 | -$130.89K derived: sum of 2 quarters · filed 2021-05-12 | -$274.74K derived: sum of 3 quarters · filed 2021-05-12 | -$325.99K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $46.96K derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-24 | -$96.88K 10-K · filed 2021-03-24 | -$148.13K derived: sum of 3 quarters · filed 2021-03-24 | -$471.91K 10-K · filed 2021-03-24 |
| 2019-09-30 | -$143.84K 10-Q · filed 2019-11-13 | -$195.09K derived: sum of 2 quarters · filed 2020-08-12 | -$524.97K 10-Q · filed 2020-11-12 | -$298.24K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-06-30 | -$51.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$381.12K 10-Q · filed 2020-08-12 | -$154.40K derived: sum of 3 quarters · filed 2020-08-12 | -$270.17K 10-K · filed 2021-03-24 |
| 2019-03-31 | -$329.87K 10-Q · filed 2020-05-15 | -$103.14K derived: sum of 2 quarters · filed 2020-05-15 | -$219.13K 10-Q · filed 2019-05-15 | $50.70K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $226.73K derived: 10-KT 6 month − 10-Q 3 month · filed 2020-03-26 | $110.74K 10-KT · filed 2020-03-26 | $380.57K derived: sum of 3 quarters · filed 2020-03-26 | $300.05K derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-09-30 | -$115.98K 10-Q · filed 2019-11-13 | $153.85K derived: sum of 2 quarters · filed 2020-03-26 | $73.32K derived: sum of 3 quarters · filed 2020-03-26 | -$55.61K derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | $269.83K derived: 10-KT 12 month − 10-Q 9 month · filed 2020-03-26 | $189.30K derived: sum of 2 quarters · filed 2020-03-26 | $60.37K derived: sum of 3 quarters · filed 2020-03-26 | -$42.74K 10-KT · filed 2020-03-26 |
| 2018-03-31 | -$80.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15 | -$209.46K derived: sum of 2 quarters · filed 2019-05-15 | -$312.57K 10-Q · filed 2019-05-15 | -$372.36K derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$128.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13 | -$232.04K 10-Q · filed 2019-02-13 | -$291.83K derived: sum of 3 quarters · filed 2019-02-13 | -$386.07K derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-09-30 | -$103.11K 10-Q · filed 2018-11-13 | -$162.90K derived: sum of 2 quarters · filed 2018-11-13 | -$257.14K derived: sum of 3 quarters · filed 2018-11-13 | -$423.13K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | -$59.79K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-28 | -$154.02K derived: sum of 2 quarters · filed 2018-09-28 | -$320.02K derived: sum of 3 quarters · filed 2018-09-28 | -$370.33K 10-K · filed 2018-09-28 |
| 2017-03-31 | -$94.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | -$260.23K derived: sum of 2 quarters · filed 2018-05-14 | -$310.54K 10-Q · filed 2018-05-14 | |
| 2016-12-31 | -$166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-12 | -$216.31K 10-Q · filed 2018-02-12 | ||
| 2016-09-30 | -$50.31K 10-Q · filed 2017-11-14 | |||
| 2015-03-31 | -$479.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $444.53K 10-Q · filed 2015-05-15 | ||
| 2014-12-31 | $923.87K 10-Q · filed 2015-02-13 | |||
| 2014-03-31 | $34.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $31.32K 10-Q · filed 2015-05-15 | ||
| 2013-12-31 | -$3.17K 10-Q · filed 2015-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |